Related Experiment Video

Updated: May 22, 2026

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation

Gregory Y H Lip1, Alessandro Proclemer, Nikolaus Dagres

  • 1University of Birmingham Centre for Cardiovascular Sciences, City Hospital Birmingham, England, UK. g.y.h.lip@bham.ac.uk

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
|April 26, 2012
PubMed

Insights

This survey of European Heart Rhythm Association centers reveals varied clinical practices for antithrombotic therapy during device implantation and atrial fibrillation ablation. However, management of periprocedure antithrombotic therapy shows some consistency with current guidelines.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Clinical Practice Research

Background:

  • Antithrombotic therapy is crucial for patients undergoing device implantation or atrial fibrillation ablation.
  • Managing antithrombotic therapy peri-procedure requires careful consideration to balance thrombosis and bleeding risks.

Purpose of the Study:

  • To survey current clinical practice regarding antithrombotic therapy use in device implantation and atrial fibrillation ablation.
  • To assess adherence to guidelines and consensus recommendations in periprocedural antithrombotic management.

Main Methods:

  • A survey was conducted across 71 centers affiliated with the European Heart Rhythm Association research network.
  • Data collected focused on antithrombotic therapy management during device implantation (pacemakers, ICDs, CRT) and AF ablation.

Main Results:

  • Significant variation in clinical practice was observed regarding antithrombotic therapy.
  • Despite variations, a degree of consistency with existing guidelines was noted for periprocedural antithrombotic management.

Conclusions:

  • Clinical practice for antithrombotic therapy in device implantation and AF ablation is heterogeneous.
  • There is reassuring consistency with guidelines for periprocedural antithrombotic management, despite practice variations.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...